Research progress of sepsis immunotherapy: a bibliometric analysis

This bibliometric analysis shows how quickly research on immunotherapy for sepsis is moving forward. It has gone from focusing on anti-inflammatory strategies to precision treatment methods based on biomarkers. The US is still the best at research results and influence, but the lack of coordination in international cooperation has made research move more slowly. Recent research domains, including immune checkpoint inhibitors and multi-omics integration, suggest a progression towards personalized algorithms. To accomplish the best clinical results, the future focus must go beyond borders, strengthen translational research, and use drugs based on biomarkers.